Finland Seeks to Lead the Silver Economy Charge

As Nordic economy faces an ageing population, its businesses seek an opportunity

Europe is slowly and steadily getting older. Today there are 3.3 people of working age — 15 to 64 — for every one over 65; by 2070 it will be just 2, according to the European Commission.

The conventional way to look at this ageing is as a huge challenge to society, public services, and governments. An older population will put immense strain on everything from healthcare to pensions. There is little sign that Europe is well prepared.

However, there is another way of viewing the shifting demographics — as an untapped opportunity for businesses to reach a new breed of customer. There has been some talk of the so-called “silver economy” but there are finally small signs that the topic is being taken more seriously in boardrooms and cabinets.

There is little surprise that one of the countries taking it most seriously is Finland. The Nordic country of 5.5m people has the most rapidly-ageing population among large EU countries and was once only behind Japan globally. Its previous centre-right government collapsed in March due to its inability to pass a healthcare reform necessary to offset the impact of an ageing population.

Finland has been thinking for decades about the effect of having an increasing number of elderly citizens. But it is only recently that business has caught up. Esko Aho, who is both a former senior executive at Nokia and ex-Finnish prime minister, is one of the movers behind a new high-level forum on the silver economy to be held in Helsinki next month.

The forum — tied into Finland’s EU presidency that starts just days earlier — brings together business leaders such as senior executives from pharmaceuticals group Bayer, insurer Aegon, and furniture retailer Ikea with policymakers including the mayor of Manchester and the president of the Federal Reserve of Kansas City.

“If we don’t do anything it will stay a problem, not an opportunity,” said Mr Aho. “But if we are able to meet these challenges, there will not be much harm for society. Maybe the opposite — people will live longer and be happier.”

He espouses the catchphrase of many in this area: “silver is the next green”. The parallels with climate change may be inexact but some are striking.

The changes from ageing are perhaps not visible day to day but over several years they certainly are. As with the early days of renewable energy, there is a lack of both a market and investors with both needing the other. “It’s like sustainability — it’s not enough to change something in the field of climate change; you have to change mindsets and the fundamental set-up of the economic system,” said Mr Aho.

For business, the size of the market is apparent but seizing the opportunity is harder. A study from last year estimated the value of the silver economy in Europe — defined as the spending by the population aged over 50 on goods and services — is €3.7tn and is expected to grow to €5.7tn by 2025, according to a European Commission study.

Some companies are an obvious fit with an ageing population. Bayer, the German pharmaceuticals group, is sending both its chief executive Werner Baumann and chief medical officer Michael Devoy to Helsinki. “As we continue to see rapidly ageing populations around the world, effectively tackling and managing age-related illnesses have become pivotal. We have to focus on addressing these unmet needs,” said Mr Devoy.

But there is an opportunity for businesses not just to provide what older people need but also what they want. Technology and entertainment groups, financial services companies, home designers, travel businesses — all are not obviously connected to ageing but each one could adapt their products better to better serve older customers. Some start-ups are active in the area but few have shot to prominence yet. Experts believe entrepreneurs and venture capitalists need to take the silver economy more seriously.

Mr Aho’s aims for the first meeting are relatively modest — to start dialogue between companies and governments while bringing the opportunities arising from an ageing population to a global audience. But as much of Europe and Asia face rapidly ageing populations over this century the need for businesses to come up with their own strategy for dealing with it will grow and grow.

Source: Financial Times

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.